| scholarly article | Q13442814 |
| P50 | author | Ebru Dündar Yenilmez | Q61100057 |
| P2093 | author name string | Abdullah Tuli | |
| Kezban Kartlaşmış | |||
| Levent Kayrın | |||
| Umut Kökbaş | |||
| P2860 | cites work | Prenatal diagnosis in maternal plasma of a fetal mutation causing propionic acidemia | Q81575251 |
| Impact of non-invasive fetal RhD genotyping on management costs of rhesus-D negative patients: results of a French pilot study | Q83564358 | ||
| Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects | Q37351817 | ||
| Genotyping approach for non-invasive foetal RHD detection in an admixed population | Q37609081 | ||
| Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance | Q38911516 | ||
| Application of fetal DNA detection in maternal plasma: a prenatal diagnosis unit experience. | Q40440447 | ||
| Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands | Q46337268 | ||
| Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology | Q47740612 | ||
| PCR-free blood group genotyping using a nanobiosensor. | Q50455912 | ||
| The proportion of fetal nucleated red blood cells in maternal blood: estimation by FACS analysis. | Q50939459 | ||
| The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. | Q54520641 | ||
| Fetal RhD genotyping by maternal serum analysis: a two-year experience. | Q54677407 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers | Q72217432 | ||
| Introduction to biosensors | Q26745882 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome. | Q33379158 | ||
| Fetal cells in the maternal circulation: feasibility for prenatal diagnosis | Q33650187 | ||
| RhD haemolytic disease of the fetus and the newborn | Q33901403 | ||
| Management of pregnancies with RhD alloimmunisation | Q33940710 | ||
| Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study | Q34132783 | ||
| Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008 | Q34306068 | ||
| Haemolytic disease of the fetus and newborn | Q34472967 | ||
| Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: an investigation into the preferences and information needs of women | Q34853996 | ||
| Non-invasive antenatal RHD typing | Q36431820 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma | Q36794228 | ||
| Non-invasive fetal sex determination: impact on clinical practice | Q37075333 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biosensor | Q669391 |
| pregnant person | Q104720811 | ||
| P304 | page(s) | e0197855 | |
| P577 | publication date | 2018-06-06 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women. | |
| P478 | volume | 13 |
Search more.